Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 4/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 2/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | RGS12 | O14924 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | POLB | P06746 | 1/20 | 1.00 |
| ▸ | APEX1 | P27695 | 1/20 | 1.00 |
| ▸ | THPO | P40225 | 1/20 | 1.00 |
| ▸ | BLM | P54132 | 1/20 | 1.00 |
| ▸ | GNAI1 | P63096 | 1/20 | 1.00 |
| ▸ | PMP22 | Q01453 | 1/20 | 1.00 |
| ▸ | CA2 | P00918 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL29382155 | 1.00 | GAA (1.00) | GAAKDM4ETDP1HSD17B10MAPT | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL8214151 | 0.98 | GAA (0.96) | GAAKDM4ETDP1HSD17B10MAPT | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL8214147 | 0.98 | GAA (0.96) | GAAKDM4ETDP1HSD17B10MAPT | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL18338957 | 0.92 | GAA (0.85) | GAAKDM4ETDP1HSD17B10MAPT | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL21381267 | 0.92 | GAA (0.85) | GAAKDM4ETDP1HSD17B10MAPT | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL175566 | 0.89 | TDP1 (0.79) | GAAKDM4ETDP1HSD17B10MAPT | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL29246309 | 0.87 | GAA (0.76) | GAAKDM4ETDP1HSD17B10MAPT | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL8565392 | 0.87 | GAA (0.76) | GAAKDM4ETDP1HSD17B10MAPT | |
| SCHEMBL2050404 | 0.84 | GAA (0.73) | GAAKDM4ETDP1HSD17B10MAPT | |
| SCHEMBL15499982 | 0.84 | GAA (0.73) | GAAKDM4ETDP1HSD17B10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6929 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122084713-A | Microelectrode, probe and electrochemical detection device | — | 2026-05-26 | — | — | CN | claimed |
| CN-116473503-B | Method for detecting refraction development effect of longitudinal chromatic aberration defocus signal on eyeball | 首都医科大学附属北京同仁医院 | 2026-05-19 | — | — | CN | claimed |
| US-12616771-B2 | Tissue adherent chitosan material that resists dissolution | TRICOL BIOMEDICAL, INC. (US) | 2026-05-05 | — | — | US | claimed |
| US-12569451-B2 | Bio-inspired tissue-adhesive hydrogel patch and uses thereof | Cellartgen Inc. (KR) | 2026-03-10 | — | — | US | claimed |
| US-20260061091-A1 | MUSSEL-INSPIRED TISSUE ADHESIVES AND METHODS OF USE THEREOF | PURDUE RESEARCH FOUNDATION (US) | 2026-03-05 | — | — | US | claimed |
| EP-4683964-A2 | POLY(ETHYLENE GLYCOL) BASED DENDRIMER-LIKE HYPERBRANCHED MACROMOLECULES, METHODS OF PREPARATION AND USE THEREOF | Ocular Therapeutix, Inc. (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4665307-A1 | BIODEGRADABLE MICROPARTICLES FOR SUSTAINED DRUG DELIVERY, METHODS OF PREPARATION AND USE THEREOF | Ocular Therapeutix, Inc. (US) | 2025-12-24 | — | — | EP | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| US-12383490-B2 | Generic high-capacity protein capture and tunable electrochemical release | NYCTEA TECHNOLOGIES AB (SE) | 2025-08-12 | — | — | US | claimed |
| EP-0031561-B1 | A RECTALLY ADMINISTERED SUPPOSITORY COMPRISING A DRUG AND AN ADJUVANT | MERCK & CO. INC. (US) | 1985-04-10 | — | — | EP | claimed |
| US-4470980-A | Method of increasing oral absorption of β-lactam antibiotics | INTERX RESEARCH CORP. (US) | 1984-09-11 | — | — | US | claimed |
| US-4406896-A | ANTIBIOTICS, ACIDS, HYDROXY | MERCK & CO., INC. (US) | 1983-09-27 | — | — | US | claimed |
| EP-0036534-A1 | An orally administrable drug form comprising a beta-lactam antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-30 | — | — | EP | claimed |
| EP-0036145-A1 | An orally administered drug form comprising a polar bioactive agent and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-23 | — | — | EP | claimed |
| EP-0035770-A2 | An orally administered drug form comprising a glycosidic antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-16 | — | — | EP | claimed |
| US-4279870-A | Liquid-liquid extraction process for the recovery of tungsten from low level sources | GTE LABORATORIES INCORPORATED (US) | 1981-07-21 | — | — | US | claimed |
| EP-0031561-A2 | A rectally administered suppository comprising a drug and an adjuvant | MERCK & CO. INC. (US) | 1981-07-08 | — | — | EP | claimed |
| US-4042329-A | Method and device for detecting cholesterol | BECTON, DICKINSON AND COMPANY (US) | 1977-08-16 | — | — | US | claimed |
| US-3964871-A | GLUCOSE OXIDASE, HORSERADISH PEROXIDASE | BECTON, DICKINSON AND COMPANY (US) | 1976-06-22 | — | — | US | claimed |